CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
|出版日||ページ情報||英文 142 Pages
|CountryFocus：ドイツの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany|
|出版日: 2019年03月14日||ページ情報: 英文 142 Pages||
当レポートでは、ドイツの医療関連市場の動向や、医療費償還制度および関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度などの制度の概略・傾向、医療規制当局や各種規制の概要、ドイツ経済・社会に関するマクロ的指標 (人口構造など) といった情報を取りまとめてお届けします。
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
Germany is a mature healthcare market, with a strong focus on pharma R&D, production, and government policies supporting higher healthcare expenditure. In 2017, Germany spent $5,728 per capita on healthcare, which was higher than the OECD average of $4,069 per capita. In 2010, Germany had pharmaceutical sales of $39.4B. This increased to $40B in 2016. The market value is expected to reach $40.5B in 2022, growing at a Compounded Annual Growth Rate (CAGR) of 0.25%. The German medical device market was valued at $28B in 2015, which increased to $33.7B in 2020, growing at a CAGR of 3.7%.The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated price-cap agreements to reduce healthcare expenditure have limited growth. The German healthcare system is characterized by universal insurance coverage, good accessibility to healthcare facilities, and adequate healthcare reimbursement. Germany offers more than 30 specialized cluster networks focusing on continuous innovation and R&D.
The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
This report will enhance your decision-making capability by allowing you to -